Based on the GlaxoSmithKline PLC ADR stock forecast from 2 analysts, the average analyst target price for GlaxoSmithKline PLC ADR is USD 50.00 over the next 12 months. GlaxoSmithKline PLC ADR’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of GlaxoSmithKline PLC ADR is Slightly Bearish, which is based on 1 positive signals and 2 negative signals. At the last closing, GlaxoSmithKline PLC ADR’s stock price was USD 35.90. GlaxoSmithKline PLC ADR’s stock price has changed by -3.00% over the past week, -7.52% over the past month and +3.19% over the last year.
No recent analyst target price found for GlaxoSmithKline PLC ADR
No recent average analyst rating found for GlaxoSmithKline PLC ADR
Company Overview GlaxoSmithKline PLC ADR
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for GlaxoSmithKline PLC ADR (GSK)
Loading...
Unadjusted Closing Price for GlaxoSmithKline PLC ADR (GSK)
Loading...
Share Trading Volume for GlaxoSmithKline PLC ADR Shares
Loading...
Compare Performance of GlaxoSmithKline PLC ADR Shares
Frequently Asked Questions About GlaxoSmithKline PLC ADR (GSK) Stock
Based on ratings from 2 analysts GlaxoSmithKline PLC ADR's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on GSK's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for GSK is USD 50.00 over the next 12 months. The maximum analyst target price is USD 53 while the minimum anlayst target price is USD 47.
Unfortunately we do not have enough data on GSK's stock to indicate if its overvalued.
The last closing price of GSK's stock was USD 35.90.
Unfortunately we do not currently have any market capitalization data for GSK's stock.
Based on targets from 2 analysts, the average taret price for GSK is projected at USD 50.00 over the next 12 months.
This means that GSK's stock price may go up by +39.28% over the next 12 months.
We can't find any ETFs which contains GlaxoSmithKline PLC ADR's stock.
Sorry, we do not have any data on the number of employees for GlaxoSmithKline PLC ADR.
Sorry we do not have any infomation available on GlaxoSmithKline PLC ADR's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
What not to like
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Frequently Asked Questions About GlaxoSmithKline PLC ADR (GSK) Stock
Based on ratings from 2 analysts GlaxoSmithKline PLC ADR's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on GSK's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for GSK is USD 50.00 over the next 12 months. The maximum analyst target price is USD 53 while the minimum anlayst target price is USD 47.
Unfortunately we do not have enough data on GSK's stock to indicate if its overvalued.
The last closing price of GSK's stock was USD 35.90.
Unfortunately we do not currently have any market capitalization data for GSK's stock.
Based on targets from 2 analysts, the average taret price for GSK is projected at USD 50.00 over the next 12 months.
This means that GSK's stock price may go up by +39.28% over the next 12 months.
We can't find any ETFs which contains GlaxoSmithKline PLC ADR's stock.
Sorry, we do not have any data on the number of employees for GlaxoSmithKline PLC ADR.
Sorry we do not have any infomation available on GlaxoSmithKline PLC ADR's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for GSK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
